Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | Linsitinib | 0.31623 | uM | 9 | 2500.00 | 1861.36 | 4486.00 | 4181.50 | 1.0728 | 1.1241 |
| SK-BR-3 | Linsitinib | 0.0033113 | uM | 9 | 2500.00 | 1861.36 | 4727.00 | 4181.50 | 1.1305 | 1.2215 |
| SK-BR-3 | 17-AAG | 0.01 | uM | 9 | 2500.00 | 1861.36 | 2974.00 | 4181.50 | 0.7112 | 0.4938 |
| SK-BR-3 | Lapatinib | 3.1623 | uM | 9 | 2500.00 | 1861.36 | 1819.00 | 4181.50 | 0.4350 | -0.0195 |
| SK-BR-3 | 17-AAG | 0.001 | uM | 9 | 2500.00 | 1861.36 | 4364.00 | 4181.50 | 1.0436 | 1.0745 |
| SK-BR-3 | 0 | uM | 9 | 2500.00 | 1861.36 | 4503.00 | 4181.50 | 1.0769 | 1.1310 | |
| SK-BR-3 | 17-AAG | 0.0031623 | uM | 9 | 2500.00 | 1861.36 | 4015.00 | 4181.50 | 0.9602 | 0.9316 |
| SK-BR-3 | Linsitinib | 1 | uM | 9 | 2500.00 | 1861.36 | 4214.00 | 4181.50 | 1.0078 | 1.0133 |
| SK-BR-3 | 0 | uM | 9 | 2500.00 | 1861.36 | 4239.00 | 4181.50 | 1.0138 | 1.0235 | |
| SK-BR-3 | 0 | uM | 9 | 2500.00 | 1861.36 | 4001.00 | 4181.50 | 0.9568 | 0.9258 | |
| SK-BR-3 | Linsitinib | 19.9526 | uM | 9 | 2500.00 | 1861.36 | 2407.00 | 4181.50 | 0.5756 | 0.2463 |
| SK-BR-3 | Linsitinib | 3.1623 | uM | 9 | 2500.00 | 1861.36 | 3367.00 | 4181.50 | 0.8052 | 0.6613 |
| SK-BR-3 | Lapatinib | 0.0033113 | uM | 9 | 2500.00 | 1861.36 | 3906.00 | 4181.50 | 0.9341 | 0.8866 |
| SK-BR-3 | Erlotinib | 0.0033113 | uM | 9 | 2500.00 | 1861.36 | 4488.00 | 4181.50 | 1.0733 | 1.1249 |
| SK-BR-3 | Linsitinib | 0.1 | uM | 9 | 2500.00 | 1861.36 | 4102.00 | 4181.50 | 0.9810 | 0.9674 |
| SK-BR-3 | Lapatinib | 0.1 | uM | 9 | 2500.00 | 1861.36 | 2269.00 | 4181.50 | 0.5426 | 0.1848 |
| SK-BR-3 | 0 | uM | 9 | 2500.00 | 1861.36 | 4129.00 | 4181.50 | 0.9874 | 0.9785 | |
| SK-BR-3 | 17-AAG | 0.000066069 | uM | 9 | 2500.00 | 1861.36 | 4214.00 | 4181.50 | 1.0078 | 1.0133 |
| SK-BR-3 | 0 | uM | 9 | 2500.00 | 1861.36 | 4310.00 | 4181.50 | 1.0307 | 1.0525 | |
| SK-BR-3 | Linsitinib | 0.01 | uM | 9 | 2500.00 | 1861.36 | 4775.00 | 4181.50 | 1.1419 | 1.2408 |
| SK-BR-3 | 17-AAG | 0.1 | uM | 9 | 2500.00 | 1861.36 | 1621.00 | 4181.50 | 0.3877 | -0.1117 |
| SK-BR-3 | Lapatinib | 0.01 | uM | 9 | 2500.00 | 1861.36 | 3472.00 | 4181.50 | 0.8303 | 0.7056 |
| SK-BR-3 | Lapatinib | 0.31623 | uM | 9 | 2500.00 | 1861.36 | 1767.00 | 4181.50 | 0.4226 | -0.0436 |
| SK-BR-3 | 17-AAG | 0.31623 | uM | 9 | 2500.00 | 1861.36 | 1397.00 | 4181.50 | 0.3341 | -0.2179 |
| SK-BR-3 | Erlotinib | 0.1 | uM | 9 | 2500.00 | 1861.36 | 4228.00 | 4181.50 | 1.0111 | 1.0190 |